Bioengineering professor and The Grainger College of Engineering's Dean, Rashid Bashir, led a team of researchers in a ...

KRRO-110 is the first RNA editing development candidate from Korro’s proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

Nature's Toolbox (NTx), a life sciences company developing next-generation platforms for RNA and protein manufacturing, today announced the founding of its Scientific Advisory Board (SAB) with ...

Beam Therapeutics announced positive initial data for BEAM-302 in the Phase I/II trial in Alpha-1 Antitrypsin Deficiency (AATD).

Researchers have identified an ancient RNA-guided system that can target DNA, potentially expanding the genome-editing toolbox.

Many biological molecules are chiral, meaning they exist in two forms that are mirror images of each other, like left and ...

Jerry Katzman, MD, CEO of RetinalGenix Technologies, will be in attendance during the conference and will be available for 1-on-1 meetings on March 17 th and 18 th. Interested investors should contact ...

CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...

On Tuesday, the team behind the plan to bring mammoth-like animals back to the tundra announced the creation of what it is ...

During the first 72 hours in particular, extracellular vesicles—nanoparticles enclosed in cell membranes—play a significant role in the embryonic development of zebrafish.